AI assistant
Aqua Bio Technology Share Issue/Capital Change 2024
3535_rns_2024-10-23_34adb48e-8ee2-4a59-922e-b082fadf4884.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
Aqua Bio Technology: Notice of extraordinary general meeting - Update on consideration to Jetcarrier sellers
23.10.2024 16:59:26 CEST | Aqua Bio Technology ASA | Additional regulated information required to be disclosed under the laws of a member state
An extraordinary general meeting of Aqua Bio Technology ASA (the "Company" or "ABT") will be held on 13 November 2024 at 10:00 (CET) at Advokatfirmaet CLP DA, Sommerrogata 13-15, 0255 Oslo. Please find attached the notice to the general meeting. All documents to be treated at the general meeting will be made available at the Company's website www.aquabiotechnology.com - http://www.aquabiotechnology.com.
Shareholders who wish to the attend the general meeting is requested to notify the Company as set out in appendix 1 to the notice within 11 November 2024 at 16:00 (CET). In case of attendance by proxy, the proxy form (also included in appendix 1 to the notice) is requested submitted to be received by the Company within the same date.
Update on consideration to Jetcarrier sellers
As announced on 17 October 2024, the Company has entered into a share purchase agreement with the shareholders of Jetcarrier AS to acquire all outstanding shares in Jetcarrier AS (the "Acquisition"). Further, as announced on 18 October 2024, the Company has placed a conditional private placement of in total 38,363,470 new shares, each at a subscription price of NOK 3.00, for total gross proceeds of approximately NOK 115.09 million (the "Private Placement"), including NOK 57 million (equal to 19 million new shares) as partial settlement of the purchase price under Acquisition.
In order to account for the issuance and listing of 5 million consideration shares to the former shareholders of 3D Innovation Nordic AS, as announced in the Company's stock exchange announcement on 29 August 2024, it has further been agreed with the sellers of Jetcarrier AS that they shall convert an additional NOK 3 million of the seller credit under the Acquisition into 1 million new shares in the Company so that they maintain the desired ownership stake after the completed Private Placement.
The board has therefore proposed issuance of these 1 million new shares to the sellers of Jetcarriers AS, in addition to the 19 million new shares proposed issued to such sellers, as previously announced.
For further information, please contact Jan Varming, CFO, telephone +47 90 83 90 76.
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
Disclosure regulation
This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.
Contacts
Jan Aas Varming, CFO, Aqua Bio Technology ASA, +47 908 39 076, [email protected]
About Aqua Bio Technology ASA
Aqua Bio Technology (ABT) is developing and commercializing sustainable biotechnology for use in skin care products. ABT's cosmetics ingredients are highly effective and they provide the cosmetics industry with natural alternatives to traditional ingredients. ABT is also marketing and distributing natural skin care products developed by partners towards consumers and professional users. Aqua Bio Technology is listed on Euronext Expand.